Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Galderma Group AG

Capitalization 43.93B 38.11B 34.46B 32.9B 59.84B 4,056B 61.94B 410B 163B 1,938B 165B 161B 6,995B P/E ratio 2026 *
51.3x
P/E ratio 2027 * 35.7x
Enterprise value 45.05B 39.08B 35.34B 33.74B 61.37B 4,160B 63.52B 421B 167B 1,987B 169B 165B 7,173B EV / Sales 2026 *
7.19x
EV / Sales 2027 * 6.1x
Free-Float
35.38%
Yield 2026 *
0.31%
Yield 2027 * 0.45%
1 day-0.75%
1 week-6.28%
Current month+0.21%
1 month-3.94%
3 months-12.30%
6 months+0.55%
Current year-9.81%
1 week 144.7
Extreme 144.7
160.8
1 month 141
Extreme 141
160.8
Current year 141
Extreme 141
167.8
1 year 72.7
Extreme 72.7
170.1
3 years 60
Extreme 60
170.1
5 years 60
Extreme 60
170.1
10 years 60
Extreme 60
170.1
Change 5d. change 1-year change 3-years change Capi.($)
-0.75%-6.28%+61.00% - 43.93B
-1.31%-4.37%-0.04%-4.96% 221B
+0.13%-2.03%-4.68%+21.38% 17.49B
+1.18%-2.11%+12.39%-50.71% 7.47B
-0.38%+0.15%+14.89%+2.35% 5.45B
+2.07%-10.48%+17.20%+6.06% 4.29B
-0.82%+1.45%-20.09%-47.85% 3.9B
+0.05%-3.66%-26.92%-31.84% 2.91B
-3.43%-6.71%+30.59%+109.09% 2.97B
-1.85%-2.33%-8.38%-64.94% 2.59B
Average -0.49%-3.13%+7.59%-6.82% 31.21B
Weighted average by Cap. -1.00%-3.40%+8.81%-4.42%

Financials

2026 *2027 *
Net sales 6.23B 5.41B 4.89B 4.67B 8.49B 575B 8.79B 58.17B 23.1B 275B 23.38B 22.88B 992B 7.33B 6.36B 5.75B 5.49B 9.99B 677B 10.33B 68.42B 27.17B 323B 27.51B 26.92B 1,167B
Net income 891M 773M 699M 667M 1.21B 82.23B 1.26B 8.31B 3.3B 39.29B 3.34B 3.27B 142B 1.42B 1.23B 1.11B 1.06B 1.93B 131B 2B 13.22B 5.25B 62.49B 5.32B 5.2B 226B
Net Debt 1.12B 972M 878M 839M 1.53B 103B 1.58B 10.45B 4.15B 49.4B 4.2B 4.11B 178B 113M 98.03M 88.63M 84.63M 154M 10.43B 159M 1.05B 419M 4.99B 424M 415M 17.99B
Logo Galderma Group AG
Galderma Group AG is a Switzerland based holding Company, specializing in dermatological treatments and skin care products. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.
Employees
7,676
Date Price Change Volume
13/03/26 146.20 CHF -0.48% 267,404
12/03/26 146.90 CHF -2.72% 1,029,336
11/03/26 151.00 CHF -2.33% 36,524,810
10/03/26 154.60 CHF -0.83% 247,627
09/03/26 155.90 CHF -0.06% 375,556
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
187.29USD
Average target price
229.48USD
Spread / Average Target
+22.53%

Quarterly revenue - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW